Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a well-established class of glucose-lowering agents that induce glucose-mediated stimulation of insulin secretion, reduce glucagon release, reduce hepatic glucose output, delay gastric emptying, increase satiety, and improve cardiovascular risk factors (69)
But it covers the full range of tirzepatide dosing up to 15mg at most concentrations
If you start a GLP-1 drug through the Bridge, treat your Part D coverage as something to review every year during the Annual Enrollment Period (October 15 to December 7) so youre not caught off guard if the rules or your plans participation change
10.1007/S12192-020-01093-1 22 BothaM.ChiangA
